Angelica Fasolo Selected Research

Angelica Fasolo Research Topics

9	Neoplasms (Cancer) 06/2022 - 11/2008
7	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2006
3	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 01/2021
2	Disease Progression 01/2022 - 01/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2012 - 03/2011
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2012 - 03/2011
1	Glioma (Gliomas) 01/2022
1	Epilepsy (Aura) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Anaplastic Thyroid Carcinoma 10/2020
1	Cholangiocarcinoma 01/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2012
1	Heart Failure 02/2009
1	Cardiotoxicity 02/2009

5	Everolimus FDA Link 01/2016 - 11/2008
3	Biomarkers (Surrogate Marker)IBA 06/2022 - 09/2009
3	Trastuzumab (Herceptin)FDA Link 01/2016 - 02/2009
3	MTOR InhibitorsIBA 01/2012 - 11/2008
3	temsirolimus FDA Link 01/2012 - 11/2008
2	spartalizumabIBA 06/2022 - 10/2020
2	dabrafenibIBA 01/2022 - 01/2020
2	trametinibIBA 01/2022 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 01/2021
2	tepotinibIBA 08/2021 - 01/2021
2	ridaforolimusIBA 03/2011 - 11/2008
1	roblitinibIBA 06/2022
1	CateninsIBA 01/2021
1	TAS-119IBA 01/2021
1	NVP-BKM120IBA 01/2021
1	AlpelisibIBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	ribociclibIBA 01/2021
1	Aurora Kinase AIBA 01/2021
1	Monoclonal AntibodiesIBA 10/2020
1	Gemcitabine FDA Link 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Estrogen ReceptorsIBA 01/2013
1	Tamoxifen FDA LinkGeneric 01/2013
1	Letrozole (Femara)FDA LinkGeneric 01/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	Sirolimus (Rapamycin)FDA Link 03/2011
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2011
1	Indicators and Reagents (Reagents)IBA 09/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2006
1	Capecitabine (Xeloda)FDA Link 10/2006
1	CarbamatesIBA 10/2006
1	Fluorouracil (Carac)FDA LinkGeneric 10/2006
1	Methotrexate (Mexate)FDA LinkGeneric 10/2006
1	ProdrugsIBA 10/2006